SALT LAKE CITY, Aug. 3 /PRNewswire-FirstCall/ -- Dynatronics Corporation today announced that it has begun shipping customers the new Dynatron X3 light therapy unit.
The new X3 features advanced light therapy technology, commonly used for treating muscle and joint pain as well as arthritis pain and stiffness. The stand-alone unit is capable of delivering three independent treatments and utilizes an interactive touch screen display, making treatment setups fast and easy. With the ability to drive two Dynatron Light Pads and a light probe simultaneously, the Dynatron X3 is the company’s most powerful light therapy device available on the market.
“While we have been delayed in releasing the new X3 product, we are confident the market will be pleased with the outcome. The delay has created a backlog of orders that we hope to resolve over the next few weeks,” reported Kelvyn H. Cullimore Jr., president of Dynatronics.
“For years, doctors and therapists have achieved excellent results using light therapy on patients who suffer from arthritis and other painful conditions,” said Larry K. Beardall, executive vice president of sales and marketing. “Clearly, light therapy is in its infancy. Growing numbers of practitioners are discovering the tremendous benefits of this important new medical modality.”
The company also plans to introduce the DX2 combination traction/light therapy device this quarter. The DX2 is the first combination device of its kind. “We believe both the X3 and DX2 products will fill important needs in the marketplace and will prove to be worth the wait,” added Beardall.
On another front, the $500,000 stock buy-back program that was announced by Dynatronics is well underway. The company is again actively purchasing its common shares on the open market. Since announcing the program in 2003, Dynatronics has purchased 134,000 shares of common stock in the open market. “Reactivating our stock repurchase program highlights the current undervaluation of our stock,” explained Cullimore.
Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, pain management, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets.
This press release contains forward-looking statements. Those statements include references to the company’s expectations, anticipated growth in sales, profitability in future periods and similar statements. Actual results may vary from the views expressed in the forward-looking statements contained in this release. The development and sale of the company’s products are subject to a number of risks and uncertainties, including, but not limited to, changes in the regulatory environment, FDA clearance of new products, growth in the physical medicine industry, competitive factors, availability of third-party component parts and products, inventory risks due to shifts in market demand, changes in product mix, market demand for the company’s products, and the risk factors listed from time to time in the company’s SEC reports, including, but not limited to the report on Form 10-KSB for the year ended June 30, 2005.
Dynatronics Corporation
CONTACT: Bob Cardon of Dynatronics Corp., +1-800-874-6251, or+1-801-568-7000
Web site: http://www.dynatronics.com//
